Leerink Partners reiterates Outperform on Eli Lilly (LLY) following orforglipron approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Leerink Partners reiterates Outperform on Eli Lilly (LLY) following orforglipron approval
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1182.99 -24.28 (2.01%)
Previous Close $1207.27    52 Week High $88.16 
Open $1194.01    52 Week Low $67.88 
Day High $1199.00    P/E 273.84 
Day Low $1171.20    EPS $4.32 
Volume 1,161,812